Therefore, we hypothesized that YSHS prevents and treats diabetic nephropathy primarily by modulating the GRP78/CHOP signaling pathway associated with ERS and ameliorating apoptosis. This evidence concerns the gene DDIT3 and diabetic kidney disease.